Literature DB >> 22564848

Deciphering the function of the outer membrane protein OprD homologue of Acinetobacter baumannii.

Manuella Catel-Ferreira1, Rony Nehmé, Virginie Molle, Jesús Aranda, Emeline Bouffartigues, Sylvie Chevalier, Germán Bou, Thierry Jouenne, Emmanuelle Dé.   

Abstract

The increasing number of carbapenem-resistant Acinetobacter baumannii isolates is a major cause for concern which restricts therapeutic options to treat severe infections caused by this emerging pathogen. To identify the molecular mechanisms involved in carbapenem resistance, we studied the contribution of an outer membrane protein homologue of the Pseudomonas aeruginosa OprD porin. Suspected to be the preferred pathway of carbapenems in A. baumannii, the oprD homologue gene was inactivated in strain ATCC 17978. Comparison of wild-type and mutant strains did not confirm the expected increased resistance to any antibiotic tested. OprD homologue sequence analysis revealed that this protein actually belongs to an OprD subgroup but is closer to the P. aeruginosa OprQ protein, with which it could share some functions, e.g., allowing bacterial survival under low-iron or -magnesium growth conditions or under poor oxygenation. We thus overexpressed and purified a recombinant OprD homologue protein to further examine its functional properties. As a specific channel, this porin presented rather low single-channel conductance, i.e., 28 pS in 1 M KCl, and was partially closed by micro- and millimolar concentrations of Fe(3+) and Mg(2+), respectively, but not by imipenem and meropenem or basic amino acids. The A. baumannii OprD homologue is likely not involved in the carbapenem resistance mechanism, but as an OprQ-like protein, it could contribute to the adaptation of this bacterium to magnesium- and/or iron-depleted environments.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22564848      PMCID: PMC3393417          DOI: 10.1128/AAC.06022-11

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  60 in total

1.  Attenuated virulence of a slow-growing pandrug-resistant Acinetobacter baumannii is associated with decreased expression of genes encoding the porins CarO and OprD-like.

Authors:  Felipe Fernández-Cuenca; Younes Smani; Ma Carmen Gómez-Sánchez; Fernando Docobo-Pérez; Francisco Javier Caballero-Moyano; Juan Domínguez-Herrera; Alvaro Pascual; Jerónimo Pachón
Journal:  Int J Antimicrob Agents       Date:  2011-09-21       Impact factor: 5.283

2.  The role of specific surface loop regions in determining the function of the imipenem-specific pore protein OprD of Pseudomonas aeruginosa.

Authors:  H Huang; R E Hancock
Journal:  J Bacteriol       Date:  1996-06       Impact factor: 3.490

3.  Carbapenem resistance mechanisms in Pseudomonas aeruginosa clinical isolates.

Authors:  H Pai; J Kim; J Kim; J H Lee; K W Choe; N Gotoh
Journal:  Antimicrob Agents Chemother       Date:  2001-02       Impact factor: 5.191

4.  Proteomic and functional analyses reveal a unique lifestyle for Acinetobacter baumannii biofilms and a key role for histidine metabolism.

Authors:  Maria P Cabral; Nelson C Soares; Jesús Aranda; José R Parreira; Carlos Rumbo; Margarita Poza; Jaione Valle; Valentina Calamia; Iñigo Lasa; Germán Bou
Journal:  J Proteome Res       Date:  2011-06-17       Impact factor: 4.466

5.  Characterization of a nosocomial outbreak caused by a multiresistant Acinetobacter baumannii strain with a carbapenem-hydrolyzing enzyme: high-level carbapenem resistance in A. baumannii is not due solely to the presence of beta-lactamases.

Authors:  G Bou; G Cerveró; M A Domínguez; C Quereda; J Martínez-Beltrán
Journal:  J Clin Microbiol       Date:  2000-09       Impact factor: 5.948

6.  Emergence and rapid spread of carbapenem resistance during a large and sustained hospital outbreak of multiresistant Acinetobacter baumannii.

Authors:  X Corbella; A Montero; M Pujol; M A Domínguez; J Ayats; M J Argerich; F Garrigosa; J Ariza; F Gudiol
Journal:  J Clin Microbiol       Date:  2000-11       Impact factor: 5.948

7.  The benPK operon, proposed to play a role in transport, is part of a regulon for benzoate catabolism in Acinetobacter sp. strain ADP1.

Authors:  Todd J Clark; Cory Momany; Ellen L Neidle
Journal:  Microbiology (Reading)       Date:  2002-04       Impact factor: 2.777

Review 8.  Function of pseudomonas porins in uptake and efflux.

Authors:  Robert E W Hancock; Fiona S L Brinkman
Journal:  Annu Rev Microbiol       Date:  2002-01-30       Impact factor: 15.500

9.  Analysis of penicillin-binding proteins (PBPs) in carbapenem resistant Acinetobacter baumannii.

Authors:  Jitendra Vashist; Vishvanath Tiwari; Rituparna Das; Arti Kapil; Moganty R Rajeswari
Journal:  Indian J Med Res       Date:  2011-03       Impact factor: 2.375

10.  Growth of Acinetobacter baumannii in pellicle enhanced the expression of potential virulence factors.

Authors:  Sara Marti; Yassine Nait Chabane; Stéphane Alexandre; Laurent Coquet; Jordi Vila; Thierry Jouenne; Emmanuelle Dé
Journal:  PLoS One       Date:  2011-10-27       Impact factor: 3.240

View more
  18 in total

1.  Loss of the OprD homologue protein in Acinetobacter baumannii: impact on carbapenem susceptibility.

Authors:  Younes Smani; Jerónimo Pachón
Journal:  Antimicrob Agents Chemother       Date:  2013-01       Impact factor: 5.191

Review 2.  Antimicrobial resistance and virulence: a successful or deleterious association in the bacterial world?

Authors:  Alejandro Beceiro; María Tomás; Germán Bou
Journal:  Clin Microbiol Rev       Date:  2013-04       Impact factor: 26.132

3.  The Acinetobacter Outer Membrane Contains Multiple Specific Channels for Carbapenem β-Lactams as Revealed by Kinetic Characterization Analyses of Imipenem Permeation into Acinetobacter baylyi Cells.

Authors:  Jorgelina Morán-Barrio; María M Cameranesi; Verónica Relling; Adriana S Limansky; Luciano Brambilla; Alejandro M Viale
Journal:  Antimicrob Agents Chemother       Date:  2017-02-23       Impact factor: 5.191

4.  Potent β-Lactam Enhancer Activity of Zidebactam and WCK 5153 against Acinetobacter baumannii, Including Carbapenemase-Producing Clinical Isolates.

Authors:  Bartolome Moya; Isabel M Barcelo; Sachin Bhagwat; Mahesh Patel; German Bou; Krisztina M Papp-Wallace; Robert A Bonomo; Antonio Oliver
Journal:  Antimicrob Agents Chemother       Date:  2017-10-24       Impact factor: 5.191

5.  Global Dynamic Proteome Study of a Pellicle-forming Acinetobacter baumannii Strain.

Authors:  Takfarinas Kentache; Ahmed Ben Abdelkrim; Thierry Jouenne; Emmanuelle Dé; Julie Hardouin
Journal:  Mol Cell Proteomics       Date:  2016-10-31       Impact factor: 5.911

6.  Analysis of tigecycline resistance development in clinical Acinetobacter baumannii isolates through a combined genomic and transcriptomic approach.

Authors:  Lin Liu; Yujun Cui; Beiwen Zheng; Saiping Jiang; Wei Yu; Ping Shen; Jinru Ji; Lanjuan Li; Nan Qin; Yonghong Xiao
Journal:  Sci Rep       Date:  2016-05-31       Impact factor: 4.379

Review 7.  Exploring bacterial outer membrane barrier to combat bad bugs.

Authors:  Ishan Ghai; Shashank Ghai
Journal:  Infect Drug Resist       Date:  2017-08-30       Impact factor: 4.003

8.  Antibiotic Resistance Determinant-Focused Acinetobacter baumannii Vaccine Designed Using Reverse Vaccinology.

Authors:  Zhaohui Ni; Yan Chen; Edison Ong; Yongqun He
Journal:  Int J Mol Sci       Date:  2017-02-21       Impact factor: 5.923

9.  In Silico Structure and Sequence Analysis of Bacterial Porins and Specific Diffusion Channels for Hydrophilic Molecules: Conservation, Multimericity and Multifunctionality.

Authors:  Hilde S Vollan; Tone Tannæs; Gert Vriend; Geir Bukholm
Journal:  Int J Mol Sci       Date:  2016-04-21       Impact factor: 5.923

10.  Pneumonia infection in mice reveals the involvement of the feoA gene in the pathogenesis of Acinetobacter baumannii.

Authors:  Laura Álvarez-Fraga; Juan C Vázquez-Ucha; Marta Martínez-Guitián; Juan A Vallejo; Germán Bou; Alejandro Beceiro; Margarita Poza
Journal:  Virulence       Date:  2018-01-01       Impact factor: 5.882

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.